These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1212121)
21. Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma. Waldorf DS; Haynes HA; Van Scott EJ Ann Intern Med; 1967 Aug; 67(2):282-90. PubMed ID: 6036390 [No Abstract] [Full Text] [Related]
22. Mycosis fungoides treated by PUVA and mustine hydrochloride. du Vivier A; Vollum D Br Med J; 1978 Nov; 2(6147):1300-1. PubMed ID: 709338 [No Abstract] [Full Text] [Related]
23. [Local Caryolysine]. Avril MF Ann Dermatol Venereol; 1987; 114(1):133-41. PubMed ID: 3579129 [No Abstract] [Full Text] [Related]
25. [Value of local applications of caryolysine in psoriasis]. Michel FJ Sem Hop Ther; 1976 Nov; 52(9):507-8. PubMed ID: 1006328 [No Abstract] [Full Text] [Related]
26. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results. Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974 [TBL] [Abstract][Full Text] [Related]
27. Results of treatment of syringomyelia with nitrogen mustard. Borysowicz J Pol Med J; 1967; 6(3):728-32. PubMed ID: 6038096 [No Abstract] [Full Text] [Related]
28. [Perforating follicular mucinosis and immediate hypersensitivity to mechlorethamine in a patient with mycosis fungoides]. Guilhou JJ; Barnéon G; Malbos S; Peyron JL; Michel B; Meynadier J Ann Dermatol Venereol; 1980; 107(1-2):59-62. PubMed ID: 7369659 [No Abstract] [Full Text] [Related]
29. [Use of topical mechlorethamine solution--a new, immunologic approach in the treatment of alopecia areata]. Stefanović Z Vojnosanit Pregl; 1988; 45(5):346-9. PubMed ID: 3218106 [No Abstract] [Full Text] [Related]
31. Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction. Brauer MJ; McEvoy BF; Mitus WJ Arch Intern Med; 1967 Oct; 120(4):499-503. PubMed ID: 6058103 [No Abstract] [Full Text] [Related]
32. [Psoriasis of the scalp]. Parier J; Dubertret L Ann Dermatol Venereol; 2002 Dec; 129(12):1405-7. PubMed ID: 12536184 [No Abstract] [Full Text] [Related]
33. The treatment of mycosis fungoides with ointment-based mechlorethamine. Price NM; Deneau DG; Hoppe RT Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680 [TBL] [Abstract][Full Text] [Related]
34. [Mustine: work environment--insecurity never ceases]. Leick C Sygeplejersken; 1997 May; 97(20):6-10. PubMed ID: 9470771 [No Abstract] [Full Text] [Related]
35. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy. Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580 [TBL] [Abstract][Full Text] [Related]
36. Topically applied mechlorethamine in the treatment of psoriasis. Mandy S; Taylor JR; Halprin K Arch Dermatol; 1971 Mar; 103(3):272-6. PubMed ID: 5548274 [No Abstract] [Full Text] [Related]
37. PUVA-induced suppression of contact sensitivity to mustine hydrochloride in mycosis fungoides. Volden G; Molin L; Thomsen K Br Med J; 1978 Sep; 2(6141):865-6. PubMed ID: 152137 [No Abstract] [Full Text] [Related]
38. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration. Price NM Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166 [TBL] [Abstract][Full Text] [Related]
39. Topical mechlorethamine therapy for early stage mycosis fungoides. Ramsay DL; Halperin PS; Zeleniuch-Jacquotte A J Am Acad Dermatol; 1988 Oct; 19(4):684-91. PubMed ID: 3183094 [TBL] [Abstract][Full Text] [Related]
40. An animal model for screening topical and systemic drugs for potential use in the treatment of psoriasis. du Vivier A; Stoughton RB J Invest Dermatol; 1975 Aug; 65(2):235-7. PubMed ID: 1151116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]